Keywords: onyx/bayer, initiate, ph, iii, nexavar, trial, germany

Onyx/Bayer initiate Ph III Nexavar trial

Article | 03 June 2009

Print This

Germany's Bayer and US drugmaker Onyx Pharmaceuticals have begun enrolling patients in an international Phase III trial to evaluate Nexavar ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in